Citizens Maintains Market Outperform Rating on NRC Health, Sets $27 Target
Citizens maintained its Market Outperform rating on NRC Health with a $27.00 price target, implying 24.1% upside from the Oct. 27 close of $21.75.
Related stories
CPV Secures $825 Million Financing for Shore and Maryland Power Plants
The financing consolidates existing project-level debt under one facility and reduces term loan costs by 75 basis points to 2.5% above SOFR. It includes a $625 million term loan an
M impact | EQUITY | Oct 29, 2026, 04:44 PM UTC
OPC Energy Financing Includes $625 Million Term Loan
The financing also includes a $125 million letter of credit and a $75 million revolver.
L impact | EQUITY | Oct 29, 2026, 04:44 PM UTC
Nasdaq Falls as Alphabet Faces Record Loss Amid AI Spending Woes
U.S. stocks are lower, with the Dow down 0.35%. Alphabet is set for a record loss amid concerns over AI spending.
M impact | EQUITY | Oct 29, 2026, 04:44 PM UTC
High Quality Food reports Q3 2026 revenue of €4.6 million
M impact | EQUITY | Oct 29, 2026, 04:44 PM UTC
High Quality Food Q3 Revenue Rises 4% to EUR 4.67 Million
M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC
CPV Secures $825 Million Financing for Two U.S. Power Plants
OPC Energy's U.S. subsidiary CPV secured $825 million in financing for the Shore and Maryland power plants. The structure consolidates existing project-level debt under a single fa
M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC